NCT02691923View on ClinicalTrials.gov

Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker

PHASE2RecruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Brain Cancer

Interventions

DRUG

Fluorescein

DRUG

Fluorescein + ALA

Trial Locations (1)

03756

RECRUITING

Sally B Mansur, Lebanon

Sponsors

Collaborators (1)

Carl Zeiss Meditec, Inc.

All Listed Sponsors

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

Carl Zeiss Meditec, Inc.

INDUSTRY

lead

David W. Roberts

OTHER

NCT02691923 - Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker | Biotech Hunter | Biotech Hunter